During Thursday’s Current trade, Shares of Visteon Corp (NYSE:VC), lost -0.61% to $100.0.
Visteon Corporation (VC) announced second-quarter 2015 results, reporting sales of $812 million and net income attributable to Visteon of $2.2 billion, or $49.73 per diluted share, including a significant gain related to the sale of Visteon’s interest in Halla Visteon Climate Control Corp. (HVCC). As a result of the previously announced divestiture of the majority of its climate business, Visteon reclassified a significant portion of climate results to discontinued operations, and recast prior periods accordingly.
- Solid financial performance
- Sales of $812 million
- Adjusted EBITDA of $60 million; net income of $2.2 billion
- Cash from operations of $31 million
Visteon Corporation designs, engineers, and manufactures products for original equipment vehicle manufacturers worldwide. It operates in three segments: Climate, Electronics, and Other. The Climate segment offers integrated heating, ventilation, and air conditioning systems, such as evaporators, condensers, heater cores, climate controls, compressors, air handling cases, and fluid transport systems; and components and modules, including radiators, oil coolers, charge air coolers, exhaust gas coolers, battery and power electronics coolers and systems, and fluid transport systems that provide cooling and thermal management for the vehicle’s engine and transmission, as well as for batteries and power electronics on hybrid and electric vehicles.
Shares of Crestwood Midstream Partners LP (NYSE:CMLP)), declined -0.11% to $8.84, during its current trading session.
(CMLP) reported its financial and operating results for the three months ended June 30, 2015
Second Quarter 2015 Highlights1
- Record Adjusted EBITDA of $125.4 million; a 14% increase over $109.7 million in the second quarter 2014 driven by a 23% and 15% decrease in adjusted operating and administrative costs from the fourth quarter 2014 and first quarter 2015, respectively2
- Net Loss of $42.2 million, compared to net income of $11.7 million in the second quarter 2014. Net loss for the second quarter 2015 includes non-cash goodwill impairments of $40.2 million. These goodwill impairments were largely attributed to discount rate increases resulting from continued commodity price volatility and the recent performance of CMLP’s unit price
Idera Pharmaceuticals Inc (NASDAQ:IDRA)), during its Thursday’s current trading session gained 0.76% to $3.35.
Idera Pharmaceuticals, Inc. (IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel nucleic acid-based therapeutics for oncology and rare diseases, today reported its financial and operational results for the second quarter ended June 30, 2015.
Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for oncology and rare diseases in the United States. It uses two proprietary drug discovery technology platforms to design and develop drug candidates, including toll-like receptor targeting technology and gene silencing oligonucleotide (GSO) technology.
Finally, Kansas City Southern(NYSE:KSU)), decreased -0.73%, to $96.73.
Kansas City Southern’s (KCS) (KSU) Board of Directors on August 3, 2015 declared a regular dividend of $0.25 per share on the outstanding KCS 4% non-cumulative preferred stock. The dividend is payable on October 6, 2015 to preferred stockholders of record at the close of business on September 14, 2015.
The Board of Directors also declared a regular dividend of $0.33 per share on the outstanding KCS common stock. This dividend is payable on October 7, 2015, to common stockholders of record at the close of business on September 14, 2015.)
Kansas City Southern, through its subsidiaries, engages in the freight rail transportation business. It operates north/south rail route between Kansas City, Missouri, and various ports along the Gulf of Mexico in Alabama, Louisiana, Mississippi, and Texas in the midwest and southeast regions of the United States.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
